Maria Hendricks: CAR-T therapy is considered a cure for some types of cancer
Maria Hendricks, Director of Clinical Research Operations for the Abramson Cancer Center (ACC) Clinical Research Unit, shared on LinkedIn:
“CAR-T therapy is considered a cure for some types of cancer. Penn researchers found significant racial disparities in who has access.
Penn researchers found significant racial disparities in who gets treated with CAR T cell therapy, which involves genetically modifying white blood cells to attack cancer. Study author Marco Ruella, MD, an assistant professor of Hematology-Oncology, is working with Carmen Guerra, MD, associate director of Diversity and Outreach for the Abramson Cancer Center, to understand why the disparities exist and develop a plan to ensure all patients can benefit from the transformative therapy. Guerra notes that these particular barriers ‘are more pronounced because CAR-T is such a uniquely complicated therapy.’ ”
Visit the article website.
Source: Maria Hendricks/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023